S-4The Raise
Enliven Therapeutics, Inc. files S-4
Filed Nov 10, 2022 · 3y ago · Accession 0001193125-22-282652
Plain English
Registration tied to a merger, acquisition, or exchange offer.
Read the source below for the full document.
Filing details
- Company
- Enliven Therapeutics, Inc.
- Ticker
- ELVN
- CIK
- 1672619
- Form type
- S-4
- Filing date
- Nov 10, 2022
- Report date
- —
- Document
- d401639ds4.htm
- Size
- 12.2 MB